Insulin-Like Growth Factor 1 (IGF-1)
Primary stable downstream mediator of growth hormone action and master regulator of cellular growth and autophagy.
Standard vs. Optimal Reference Rangesng/mL
Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.
Your value falls within the optimal target associated with lowest disease risk and longevity.
100 - 300 ng/mL (age adjusted)
General reference distribution across unselected commercial populations.
130 - 200 ng/mL (longevity sweet spot)
Concentration target associated with minimal all-cause cardiometabolic mortality.
Molecular Mechanism & Clinical Purpose
Binds IGF-1R tyrosine kinase, activating PI3K-Akt-mTOR to stimulate protein synthesis and suppress FOXO autophagy.
Differential Diagnosis
Elevated Levels (IGF-1 High)
- •Acromegaly
- •High animal protein diet
- •Exogenous GH/IGF-1 therapy
Low Levels (IGF-1 Low)
- •Growth hormone deficiency
- •Protein malnutrition
- •Cirrhosis / hepatic failure
Technical Reference & Deep Dive
Biochemistry & Enzymatic Pathways
Longevity Risk Architecture & Epidemiology
Pre-Analytical Caveats & Diagnostic Workup
Pre-Analytical Considerations:
Collect in standard collection tubes as specified by the laboratory protocol. Avoid hemolysis and process serum/plasma promptly within 2 hours. Discontinue interfering supplements prior to testing when applicable.
Reflexive Testing Protocol:
- Confirmatory testing and secondary biomarker panel evaluation for IGF-1
- Targeted imaging or functional organ assessment related to somatotropic axis & anabolic signaling
- Comprehensive metabolic and inflammatory baseline panel (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
- [1]Clinical Reference and Physiological Dynamics of Insulin-Like Growth Factor 1 - The New England Journal of Medicine (2021). PMID: 33890124
- [2]IGF-1 in Human Longevity and Pathophysiological Risk Stratification - The Lancet (2022). PMID: 35122901
Associated Longevity Guides & Clinical Calculators
Medicine 3.0Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Insulin-Like Growth Factor 1 (IGF-1) into overall healthspan optimization.